BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Butylscopolammonium Bromide

the gastrointestinal tract.

33+ PubMed studies analyzed · 15 RCTs · Evidence Score: 50.5

Research Domains

Butylscopolammonium Bromide has been studied across 13 research domains including 😴 Sleep, 💊 Pain, 🦠 Gut & Microbiome, 🫘 Kidney, ❤️ Cardiovascular. The primary research focus is 😴 Sleep with 27% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Butylscopolammonium Bromide, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

trihexyphenidyl
4 shared targets
carbachol
3 shared targets
pirenzepine
3 shared targets
oxotremorine
3 shared targets
4
3 shared targets
methscopolamine
3 shared targets
solifenacin
3 shared targets
himbacine
3 shared targets
aclidinium
3 shared targets
glycopyrronium
3 shared targets
Loading evidence profile...

This evidence profile for Butylscopolammonium Bromide is generated deterministically from 33 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.